Pancreatic Elastase Chemiluminescence ELISA
Exocrine pancreatic insufficiency
Approved/CommercialMarketed (IVD in U.S.)
Key Facts
Indication
Exocrine pancreatic insufficiency
Phase
Approved/Commercial
Status
Marketed (IVD in U.S.)
Company
About ALPCO Diagnostics
Founded in 1991 as the American Laboratory Products Company, ALPCO has evolved from a distributor into a leading global diagnostics firm. Its strategic merger with GeneProof in April 2022 significantly expanded its capabilities in molecular diagnostics. The company now provides integrated platforms for immunodiagnostics and PCR-based molecular diagnostics, serving clinical and research laboratories with high-quality, automated testing solutions.
View full company profile